Preliminary reports show conolidine may well inhibit certain ion channels, reducing neuronal excitability and limiting ache indicators. This mechanism is particularly suitable in neuropathic suffering, in which abnormal signaling triggers persistent pain. On top of that, conolidine appears to influence G protein-coupled receptor (GPCR) pathways int